Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion

Annals of Surgical Oncology

Volumn 16, Issue 5, 2009, Pages 1287-1294

  Strzelczyk, Barbara ^a   Szulc, Aneta ^a   Rzepko, Robert ^a   Kitowska, Agnieszka ^a   Skokowski, Jaroslaw ^a   Szutowicz, Andrzej ^a   Pawelczyk, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME;

AGED; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 64249171384     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0381-0     Document Type: Article

References (28)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
2. A Jemal R Siegel E Ward 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66
3. BM Wolpin JA Meyerhardt HJ Mamon RJ Mayer 2007 Adjuvant treatment of colorectal cancer CA Cancer J Clin 57 168 185
4. JP Kuebler HS Wieand MJ O'Connell 2007 Oxaliplatin combined with weakly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 J Clin Oncol 25 2198 2204
5. R Nauta DM Stablein ED Holyoke 1989 Survival of patients with stage B2 colon carcinoma: the Gastrointestinal Tumor Study Group Experience Arch Surg 124 180 182
6. P Michel V Merle A Chiron 1999 Postoperative management of stage II/III colon cancer: a decision analysis Gastroenterology 117 784 793
7. Y-C Chen DJ Hunter 2005 Molecular epidemiology of cancer CA Cancer J Clin 55 45 54
8. O Riesterer L Milas KK Ang 2007 Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy J Clin Oncol 25 4075 4083
9. WL Allen PG Johnston 2005 Role of genomic markers in colorectal cancer treatment J Clin Oncol 23 4545 4552
10. RJ Guan HL Ford Y Fu 2000 Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer Cancer Res 60 749 755
11. S Bandyopadhyay SK Pai SC Gross 2003 The Drg-1 gene suppresses tumor methastasis in prostate cancer Cancer Res 63 1731 1736
12. M Motwani FM Sirotnak Y She T Commes GK Schwartz 2002 Drg-1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells Cancer Res 62 3950 3955
13. MA Shah N Kemeny A Hummer 2005 Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes Clin Cancer Res 11 3296 3302
14. CL Andersen JL Jensen TF Orntoft 2004 Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets Cancer Res 64 5245 5250
15. N Van Belzen WN Dinjens MP Diesveld 1997 A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms Lab Invest 77 85 92
16. Z Wang F Wang W-Q Wang 2004 Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm World J Gastroenterol 10 550 554
17. M Koshiji K Kumamoto K Morimura 2007 Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity World J Gastroenterol 13 2803 2810
18. Z Kovacevic DR Richardson 2006 The metastasis suppressor, Ndrg-1: a new ally in the flight against cancer Carcinogenesis 27 2355 2366
19. TP Ellen Q Ke P Zhan M Costa 2008 NDRG1, a growth and cancer related gene: regulation of the gene expression and function in normal and disease states Carcinogenesis 29 2 8
20. P Lachat P Shaw S Gebhard 2002 Expression of NDRG1, a differentiation-related gene, in human tissues Histochem Cell Biol 118 399 408
21. S Bandyopadhyay SK Pai S Hirota 2004 Role of the putative tumor metastasis suppressor gene Drg1 in breast cancer progression Oncogene 23 5675 5681
22. T Ando H Ishiguro M Kimura 2006 Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma Dis Esophagus 19 454 458
23. C Compton CM Fenoglio-Preiser N Pettigrew LP Fielding 2000 American Joint Committee on Cancer Prognostic Factors Consensus Conference. Colorectal Working Group Cancer 88 1739 1757
24. S Ramaswamy KN Ross ES Lander TR Golub 2003 A molecular signature of metastasis in primary solid tumors Nat Genet 33 49 54
25. T Kan Y Shimada F Sato 2004 Prediction of lymph node metastasis with use of artificial neural network based on gene expression profiles in esophageal squamous cell carcinoma Ann Surg Oncol 11 1070 1078
26. S Eschrich I Yang G Bloom 2005 Molecular staging for survival prediction of colorectal cancer patients J Clin Oncol 23 3526 3535
27. O Riesterer L Milas KK Ang 2007 Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy J Clin Oncol 25 4075 4083
28. ALB Benson III D Schrang MR Somerfield 2004 American Society of Clinical Oncology recommendation on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 3408 3419